Time delay toxin activation

From Wikipedia, the free encyclopedia

Time Delay Toxin Activation

Time Delay Toxin Activation (TDTA) belongs to a class of chemotherapy drugs known as High Specificity Anticancer Agents. This is a process for manufacturing and administering chemotherapy drugs in a nontoxic, proto-drug form. Then, after a time delay to allow for concentration in the target cancer or invasive tissues or cells, the non-toxic drug is then modified by an activation drug to selectively provide toxic levels of a pharmacologically active agent to the target issue. This minimizes the toxicity to healthy cells, reducing the adverse side-effects of chemotherapy.

[edit] References

• US Patent Office application number 20040192578. Retrieved on February 02, 2006.

• High specificity anticancer agents. USPTO Full text patent database. Retrieved on January 29, 2006.